A randomised, double blind, placebo-controlled study of the effects of Dehydroepiandrosterone (DHEA) replacement on vascular function in patients with primary and secondary adrenal insufficiency
Not Applicable
Completed
- Conditions
- Primary and secondary adrenal insufficiencyNutritional, Metabolic, Endocrine
- Registration Number
- ISRCTN46268487
- Lead Sponsor
- Cardiff University (UK)
- Brief Summary
2009 results on http://www.ncbi.nlm.nih.gov/pubmed/19318448
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Individuals with at least a 4 year history of primary adrenal insufficiency and those with secondary adrenal insufficiency as a result of pituitary surgery for a non-functioning pituitary tumour who did not receive radiotherapy and who are on stable doses of full hormone replacement including growth hormone.
Exclusion Criteria
Not provided at time of registration
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method